glutathione parkinsons perlmutter Research progress on intranasal treatment for Parkinson's disease A randomized, double‐blind phase I/IIa
Description
[DOI] [PubMed] [Google Scholar] 186.Traina G., Federighi G., Brunelli M., Scuri R
Ryan BM, Molloy AM, McManus R, Arfin Q, Kelleher D, Scott JM, Weir DG
FDR p = 0.016), inositol (r = 0.47
Additionally, if you have underlying medical conditions that affect nutrient absorption or metabolism, this can also influence the duration of their presence in your system
Y.et al (2001)
